Proteomic Differences in Normal and Glaucomatous Optic Nerve
About the Research Project
Program
Award Type
Standard
Award Amount
$35,000
Active Dates
April 01, 2004 - March 31, 2005
Grant ID
G2004047
Summary
The mechanism by which the optic nerve undergoes structural and functional damage in glaucoma is poorly understood. Dr. Bhattacharya’s goal is to determine the differential protein profile between normal and glaucomatous optic nerves using mass spectrometry and protein modifications. These protein changes will be studied using Western analyses and mass spectrometry. It is hoped that the identification of proteins and protein modifications may serve as markers for individuals predisposed to an increased risk of developing glaucoma. This information should provide insight into the pathologic mechanisms associated with glaucoma, and could help identify possible new drug targets for glaucoma therapy.
Grantee institution at the time of this grant: Cleveland Clinic Foundation
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
Assessment of Vascular Resistance in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Brad Fortune, OD, PhD
Current Organization
Legacy Devers Eye Institute
National Glaucoma Research
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear
Interleukin-10 As a Neuroprotective Factor in Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Tatjana Jakobs, MD
Current Organization
The Schepens Eye Research Institute, Mass. Eye and Ear